HIGHLIGHTS
- who: Peter Wahlqvist and collaborators from the CeQur (Wales) Ltd, Life Science Hub Wales, Cardiff, Wales, United Kingdom have published the paper: Journal of Health Economics and Outcomes Research, in the Journal: (JOURNAL)
- what: This study was conducted to compare the cost-effectiveness of a simple insulin infusion device to MDI for individuals with T2D not in glycemic control on MDI, where effectiveness data were obtained from the OpT2mise trial . This suggests that the estimates from the current model are very conservative compared with potential estimates made using the CORE model.
SUMMARY
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.